Compare Roblox Corp (RBLX) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Roblox Corp vs TransMedics Group Inc — how do they compare? Roblox Corp trades at $44.66 (market cap $32.02B), while TransMedics Group Inc trades at $85.89 (market cap $3.06B). The key difference: Roblox Corp is far larger — about 10.5× TransMedics Group Inc's market cap, and TransMedics Group Inc is trading nearer its 52-week high, Roblox Corp nearer its low. Which is the better fit depends on your goals.
| RBLX | TMDX | |
|---|---|---|
Market Cap | $32.02B | $3.06B |
Sector | Media | Technology |
52-Week High | $141.56 | $150.42 |
52-Week Low | $35.54 | $61.99 |
Enterprise Value | $30.84B | $3.46B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Roblox (RBLX) trades at $44.82, up 3.49% today, with a bullish technical signal and strong revenue growth to $4.89B in 2025, though net losses persist. Recent earnings beats and positive cash flow trends contrast with high valuation ratios and regulatory scrutiny. The stock is near its consensus price target of $45.71, with support at $43 and resistance at $46.
Outlook: Long-term growth potential via user engagement and creator economy is tempered by profitability challenges and child-safety regulations. Risks include sustained losses and competitive pressure, but analyst sentiment leans slightly bullish with 44.74% buy ratings. Investors should weigh revenue momentum against margin improvement needs.
TransMedics Group (TMDX) trades at $88.27, down 1.9% on the day, with a bullish technical signal from moving averages but mixed earnings results. The company reported strong revenue growth to $605.49M in 2025, with a net income margin of 22.69%, though profitability is expected to moderate in 2026. Recent news highlights ongoing legal investigations into fiduciary duties alongside positive coverage of growth initiatives in kidney transplantation and European expansion.
The stock presents a growth opportunity with analyst consensus pointing to a $99.57 price target, but risks include margin pressure from heavy investments and legal uncertainties. Earnings misses in recent quarters and a projected decline in net income for 2026 warrant caution, though institutional interest remains with a bullish rating from 69% of analysts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Roblox Corp
Roblox operates an online video game platform that lets young gamers create, develop, and monetize games (or experiences) for other players. The firm effectively offers its developers a hybrid of a game engine, publishing platform, online hosting and services, marketplace with payment processing, and social network. The platform is a closed garden that Roblox controls, earning revenue in multiple places while benefiting from outsourced game development. Unlike traditional video game publishers, Roblox is more focused on the creation of new tools and monetization techniques for its developers then creating new games or franchises. Roblox is increasingly focused on creating a metaverse that moves beyond games toward experiences like concerts, education, and even business management.
Read more on RBLX →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
